| Patient | Samuel Johnson |
|---|---|
| Date of birth | 1709-09-18 |
| Identifiers | MRN HR-EN008-SYN-TD; SSN (made up) 000-08-7139 |
| Document date | 1765-05-18 |
| Author | Catriona Bell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week depression review. [S]
Mr. Johnson returns six weeks after starting sertraline 50 mg. He is a little better: he has written letters, though not his book, and walked out with a friend twice. He still wakes in the early morning with dread and reproaches himself for idleness. He has had five psychotherapy sessions and the first two sessions of behavioral therapy for tics, in which he is learning to notice the urge before the head-shaking tic and to answer it with a competing movement. He has no side effects. [S]
| Element | Detail |
|---|---|
| Sertraline | 50 mg daily for six weeks |
| Mood | PHQ-9 15; GAD-7 9 |
| Psychotherapy | Five sessions |
| Tic therapy | Two sessions |
| Side effects | None |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight change or sweats |
| Neurological | Positive | Tics as before |
| Psychiatric | Positive | Mood a little better; early waking; no thoughts of suicide or self-harm |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-04-06 to 1765-05-18 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-05-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1765-05-18 | Body height | 183 | cm | S |
| 1765-05-18 | Body weight | 98.2 | kg | S |
| 1765-05-18 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 1765-05-18 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1765-05-18 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1765-05-18 | Heart rate | 78 | /min | S |
| 1765-05-18 | Respiratory rate | 14 | /min | S |
| 1765-05-18 | Body temperature | 36.7 | Cel | S |
| 1765-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1765-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 15 | {score} | S | ||
| 1765-05-18 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S |
Vital signs recorded on 1765-05-18; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Better groomed; blood pressure 124/78, pulse 78 |
| Neurological | Tics as described at the consultation |
| Psychiatric | Less slowed; reactive affect |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholy | active | confirmed | F33.2 | S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health. |
| Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requested | resolved | confirmed | F95.9 | S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation. |
| Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosis | active | confirmed | F95.2 | S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact. |
| Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eye | active | confirmed | H54.42 | S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Depression measure (PHQ-9) | At baseline and at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 15, from 21: partial response |
| Medication safety | Sertraline adherence and adverse effects | Every visit in the acute phase; reassess at 2 weeks after starting and after each dose change | Completed today | No side effects; increased to 100 mg |
| Survey | Suicide-risk review (PHQ-9 item 9 and structured questions since the last visit), safety plan, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm |
| Referral | Psychotherapy (cognitive behavioral therapy with behavioral activation) | Offer to all with moderate or severe depression | Completed today | Five sessions |
| Survey | Anxiety measure (GAD-7) | At baseline and with PHQ-9 reviews | Completed today | 9, from 12 |
| Survey | Tic severity (Yale Global Tic Severity Scale, recorded in the note; no LOINC code is used) | At diagnosis and periodically to judge the need for and response to treatment | Due | At three months |
| Referral | Comprehensive Behavioral Intervention for Tics | Offer as an initial treatment option | Completed today | Two of eight sessions |
| Medication safety | Tic-suppressing medication (alpha-2 agonist, aripiprazole, or other) | When tics cause impairment that behavioral therapy does not relieve | Not indicated | Not needed |
Goal progress:
Guideline basis: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Review in five weeks. Psychotherapy weekly; tic therapy weekly. Next scheduled visit 1765-06-22: eleven-week review of depression and tics. [S]